Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc 3.10%13.651.6%$125.59m
JAZZJazz Pharmaceuticals Plc 0.00%96.962.3%$94.15m
PRGOPerrigo Co. Plc 0.11%46.106.8%$90.54m
VRXValeant Pharmaceuticals International, Inc. 1.59%14.7014.1%$86.50m
CTLTCatalent, Inc. -3.05%48.892.2%$71.98m
UTHRUnited Therapeutics Corp. 0.00%91.3214.3%$70.23m
ICLRICON plc -1.27%135.044.2%$65.46m
AXSMAxsome Therapeutics, Inc. -14.89%53.851.9%$59.47m
GWPHGW Pharmaceuticals Plc -2.92%83.256.2%$58.44m
HZNPHorizon Therapeutics Plc -3.06%27.536.5%$56.91m
SAGESAGE Therapeutics, Inc. 0.00%31.508.6%$47.67m
ICPTIntercept Pharmaceuticals, Inc. -0.11%65.0016.8%$45.35m
ZGNXZogenix, Inc. -1.27%23.369.2%$36.34m
PBHPrestige Consumer Healthcare, Inc. 3.22%36.284.0%$31.61m
PCRXPacira Biosciences, Inc. 0.00%31.7310.4%$31.20m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.